Evidence map›Paper›PMID 23668303›Full record

ArticleThe FEBS journal2013

The secondary structure of apolipoprotein A-I on 9.6-nm reconstituted high-density lipoprotein determined by EPR spectroscopy.

Michael N Oda, Madhu S Budamagunta, Mark S Borja, Jitka Petrlova, John C Voss, Jens O Lagerstedt

Open access · hybridAbstract read
In one paragraph

Article in The FEBS journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Apolipoprotein A-I: A Molecule of Diverse Function.Indian journal of clinical biochemistry : IJCB · 2016
    Review
  8. Review
  9. Article
  10. Conformational and aggregation properties of the 1-93 fragment of apolipoprotein A-I.Protein science : a publication of the Protein Society · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Michael N OdaChildren's Hospital Oakland Research Institute, CA, USA.
Madhu S Budamagunta
Mark S Borja
Jitka Petrlova
John C Voss
Jens O Lagerstedt
Lund University · SEUniversity of California, Davis · US

Funding

Structure of apolipoprotein A-I on defined states of HDLR01HL077268 · NHLBI · CHILDREN'S HOSPITAL &RES CTR AT OAKLAND · PI ODA, MICHAEL NOBUAKI · 2004 to 2010
$2.0M
NHLBI NIH HHS HL77268NHLBI NIH HHS R01 HL077268
6 · The paper itself

Abstract

Apolipoprotein A-I (ApoA-I) is the major protein component of high-density lipoprotein (HDL), and is critical for maintenance of cholesterol homeostasis. During reverse cholesterol transport, HDL transitions between an array of subclasses, differing in size and composition. This process requires ApoA-I to adapt to changes in the shape of the HDL particle, transiting from an apolipoprotein to a myriad of HDL subclass-specific conformations. Changes in ApoA-I structure cause alterations in HDL-specific enzyme and receptor-binding properties, and thereby direct the HDL particle through the reverse cholesterol transport pathway. In this study, we used site-directed spin label spectroscopy to examine the conformational details of the ApoA-I central domain on HDL. The motional dynamics and accessibility to hydrophobic/hydrophilic relaxation agents of ApoA-I residues 99-163 on 9.6-nm reconstituted HDL was analyzed by EPR. In previous analyses, we examined residues 6-98 and 164-238 (of ApoA-I's 243 residues), and combining these findings with the current results, we have generated a full-length map of the backbone structure of reconstituted HDL-associated ApoA-I. Remarkably, given that the majority of ApoA-I's length is composed of amphipathic helices, we have identified nonhelical residues, specifically the presence of a β-strand (residues 149-157). The significance of these nonhelical residues is discussed, along with the other features, in the context of ApoA-I function in contrast to recent models derived by other methods.

Indexed as

Apolipoprotein A-IElectron Spin Resonance SpectroscopyHumansLipoproteins, HDLModels, MolecularProtein Structure, SecondaryProtein Structure, TertiaryApolipoprotein A-ILipoproteins, HDLapolipoprotein A-I (ApoA-I)cardiovascularcholesterolEPR spectroscopyhigh-density lipoprotein (HDL)

Identifiers

PMID23668303
PMCPMC3906832
OpenAlexW1981223744

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.